This narrative review (Cell Communication and Signaling, 2025) synthesizes ~130 primary papers on ATG9A, positioning it as the only transmembrane protein of the core autophagy machinery: a homotrimeric lipid scramblase whose central pore equilibrates bilayer leaflets, enabling phagophore expansion . Its chief mechanistic strength is the TMEM41BβATG2AβATG9A lipid-delivery axis: ATG2A transfers phospholipids from ER to the growing phagophore, while ATG9A scrambles the receiving leaflet, and disruption of the heterotetrameric ATG9AβATG2A complex breaks autophagic flux .
BGPT tabulation of cited evidence density (count of distinct regulatory modules per review section); bars reflect the review's coverage emphasis, not primary measurements. Error bars indicate approximate uncertainty in our subjective module counts.
The trafficking section is the review's most thorough contribution: it integrates AP-4βdependent TGN export via the Β΅4/YXXΓE motif with kinesin/dynein adaptors (RUSC2 vs WDR47/FHF), actin-dependent endosomal sorting (annexin A2, SNX18), and Rab11βRab1 switching via TBC1D14βTRAPPIII. The non-autophagic functionsβESCRT-linked plasma-membrane repair via IQGAP1 , MARCHF9/GRASP55 Golgi dynamics, and chemotactic migrationβare well sourced and genuinely broaden ATG9A's functional scope.
The review has several notable gaps it partially acknowledges but does not fully develop. First, it omits (or underweights) two recent mechanistic advances that change the field's picture: (a) a lipid-transferβdependent feedback loop in which ATG2A supplies PI to otherwise PI-poor ATG9A compartments to license PI3P production and LC3 lipidation ; and (b) dynamin-2βdependent retrieval of ATG9A from phagophores, defining a recycling step the review flags as an open question but for which data now exist . Second, the disease/prognosis section aggregates observational, mostly immunohistochemistry- and bioinformatics-based associations (OSCC, ovarian, HCC, IDD) without addressing confounding, cohort heterogeneity, or causal direction β appropriate caution is absent. Third, cross-species claims (C. elegans, zebrafish, mouse, human) are mixed throughout without flagging mechanistic divergence. Fourth, the review is purely qualitative β no tables, quantitative summaries, or structural figures of the scramblase pore mutants (N265W, R422W) that would help readers judge the evidence.
Radar of qualitative evidence maturity per domain, assessed by BGPT from the cited literature β not reported scores from the paper.
Core claims would fail if ATG9A proved dispensable for autophagosome formation across cell types, if AP-4βindependent trafficking fully rescues autophagy, or if ATG9A scramblase activity were not required in vivo (e.g., conditional rescues with pore-dead mutants in animal models β still lacking). The review's disease links would be falsified by large, independent cohorts showing no ATG9Aβprognosis association.
Bottom line: a competent, wide-ranging narrative review with strong sourcing on trafficking and lipid delivery, but weak quantitative synthesis, limited critical appraisal of disease associations, and a reference list that predates several pivotal 2025β2026 mechanistic advances. Use it as an entry point, not a definitive map.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.